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The aim of the present study was to generate an experimental model to characterize the 18 
nutrigenomic profile of a plant-derived nutritional stress. Atlantic salmon (Salmo salar) was 19 
used as the model species. The nutritional stress was induced by inclusion of dietary defatted 20 
soybean meal (SBM), as this ingredient had been previously demonstrated to induce 21 
enteropathy in the distal intestine and reduce growth in salmon. Triplicate groups of Atlantic 22 
salmon were fed increasing concentrations (0, 100, 200 and 300 g kg
-1
) of SBM for 12 weeks 23 
and reduced growth performance was used as the indicator of nutritional stress. The 24 
transcriptome was analysed in two tissues, liver and distal intestine, with the hypothesis being 25 
that the liver transcriptome would be characterized by gene expression responses related to 26 
overall growth and health performance, whereas intestinal gene expression would be 27 
dominated by specific responses to SBM. A set of 133 genes was differentially expressed in 28 
liver including 44 genes in common with the intestinal response. The liver specific response 29 
included up-regulation of genes involved in protein digestion, energy metabolism and 30 
immune functions, whereas genes regulated in other metabolic pathways were generally 31 
anabolic and down-regulated. These responses may be more related to general nutritional 32 
stress than to SBM per se. The transcriptomic profile in the distal intestine was consistent 33 
with the enteritis response as described previously. This study provides a comprehensive 34 
report on the profiles of liver and distal intestine transcriptomes, highlighting the role of the 35 
former tissue in fish undergoing SBM-induced nutritional stress.  36 
  37 
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1. Introduction 38 
Aquaculture is a major player of the global food security program producing approximately 39 
fifty percent of the world seafood supply (The World Bank, 2013). In an effort to provide the 40 
growing population with a consistent supply of high-quality and sustainable seafood, 41 
alternative sources of protein to the traditionally used fishmeal (FM) are now being sought 42 
after, particularly for industries involved in the farming of carnivorous fish species such as 43 
Atlantic salmon (Salmo salar). Over the last two decades, significant research investment has 44 
been made to identify alternative sources of protein that could fulfil the requirements of these 45 
fish, provide a competitive growth rate and good flesh properties, and avoid any negative 46 
impact on fish welfare. Thus far, plant-based ingredients have proved to be a potentially 47 
attractive and sustainable alternative mainly due to a competitive market price and 48 
availability. The use of plant protein products such as soybean, pea and other legumes, wheat 49 
and corn gluten is either already established in commercial feed manufacturing protocols or is 50 
proven to be a viable alternative to FM (Gatlin et al., 2007).   51 
One limitation of plant-based products, however, is the presence of chemical compounds 52 
known as antinutritional factors (ANFs), endogenously produced by the plant with a variety 53 
of functions including structural (e.g. fibres), storage (e.g. phytic acid) or as defence 54 
mechanisms (e.g. saponins, lectins and protease inhibitors; reviewed by Francis et al., 2001, 55 
Gatlin et al., 2007, Krogdahl et al., 2010). Processes to concentrate protein in plant products 56 
can lower the concentration of ANFs, but ANFs can also co-purify with proteins and be 57 
present in protein concentrates utilized as an alternative to FM. Fish are generally not able to 58 
metabolize ANFs and when these are present in their diets they can cause a number of effects 59 
primarily associated with digestive physiology, health and metabolism, impacting on fish 60 
welfare and resulting in reduced productivity (Francis et al., 2001). For example, substances 61 
such as fibre and phytic acid can affect the uptake and utilization of micronutrients, while 62 
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protease inhibitors, saponins and phytosterols can interfere with the digestion and/or 63 
absorption of proteins, lipids and cholesterol, respectively (Gatlin et al., 2007). In addition, 64 
some ANFs such as saponins and lectins can have important health consequences primarily 65 
affecting the intestinal mucosa, causing inflammation and increasing the permeability to 66 
pathogens and other unwanted substances (Krogdhal et al., 2010). It follows that the 67 
nutritional profile of plant-based protein raw materials does not always reflect the true value 68 
available to the animal for absorption and utilization, but varies depending on the presence 69 
and abundance of ANFs.  70 
Understanding how fish respond to and utilize dietary plant ingredients has therefore been a 71 
key topic of research in recent years. The study of individual ANFs has been a useful 72 
approach to unveil mechanisms behind the biological response of fish to these chemicals and 73 
research in this direction will continue to provide crucial information (Buttle et al., 2001, 74 
Francis et al., 2002, Krogdahl et al., 2010). However, from a commercial and applied 75 
perspective it is critical to maintain a holistic approach particularly as it is increasingly 76 
evident that certain effects are only visible when two or more ANFs are present in 77 
combination (Kortner et al., 2012, Krogdahl et al., 2010). The high-demand for alternative 78 
protein sources continues to be a strong driver for research testing novel raw materials 79 
individually or in combination (Azaza et al., 2009, Booth et al. 2001, Glencross et al., 2005, 80 
Hartviksen et al., 2014, Kaushik et al., 2004, Kortner et al., 2013, Øverland et al., 2009, 81 
Panserat et al., 2009). In addition, novel processing technologies are contributing to the 82 
introduction of new products from the same raw materials but with improved nutritional 83 
characteristics and reduced levels of ANFs. When testing ingredients with reduced levels of 84 
ANFs, a macroscopic physiological response might not be measurable in short-term 85 
experimental trials, whereas cumulative adverse effects, gut pathologies or other detrimental 86 
physiological conditions might accrue under long-term or more challenging commercial 87 




It is therefore increasingly important at experimental levels to have sensitive tools at our 90 
disposal that are able to detect subtle physiological changes and help predict long-term 91 
detrimental effects of dietary modification. This approach is the foundation of nutrigenomics, 92 
a science still in its infancy that studies the influence of food or food constituents on the 93 
transcriptome. In nutrigenomics, nutrients are considered signals through which cells interpret 94 
information about the environment (diet) and respond, according to necessity, by modifying 95 
metabolic pathways through regulation of gene and protein expression towards homeostasis 96 
(Muller and Kersten, 2003). Nutrigenomics can provide a means to interpret how dietary 97 
ingredients are perceived by fish at the tissue level and also provide a molecular snapshot of 98 
the physiological response of specific tissues. Nutrigenomic studies have utilized both 99 
candidate gene and high-throughput approaches to investigate the physiological responses of 100 
tissues and mechanisms of adaptation to plant-based dietary ingredients in fish or to 101 
understand the molecular mechanisms underlying pathologies such as enteritis caused by 102 
these ingredients (Gu et al., 2014, Kortner et al., 2012, Kortner et al., 2013, Panserat et al., 103 
2009, Tacchi et al., 2012, Wacyk et al., 2012). However, in order to develop a practical 104 
diagnostic use of nutrigenomic approaches, it is essential to determine “dietary signatures” 105 
that characterize the physiological response to nutritional stressors.   106 
The overarching aim of the present study was to generate an experimental model to 107 
characterize the nutrigenomic profile of a plant-derived nutritional stress. A nutritional stress 108 
was induced in Atlantic salmon using dietary defatted soybean meal (SBM), which has been 109 
demonstrated to induce enteropathy in the distal intestine (Baeverfjord and Krogdahl, 1996, 110 
Urán et al., 2008, Urán et al., 2009). Impaired growth was taken as an indicator of pronounced 111 
nutritional stress. Transcriptomic analyses were performed in two tissues, liver and distal 112 
intestine. Liver was chosen for being arguably the key metabolically active tissue responding 113 
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to diet, while the distal intestine has been studied for the development of specific pathologies 114 
associated with plant ingredients such as SBM (Baeverfjord and Krogdahl, 1996, Kortner et 115 
al., 2012). The results provided: a) an insight into the molecular signatures resulting from a 116 
nutritional stress response to which future nutrigenomic studies can refer to; and b) a platform 117 
for the identification of candidate genes for the molecular phenotyping of several 118 
physiological parameters in liver and distal intestine. These data were specifically analysed to 119 
test the hypothesis that the liver transcriptome would include gene expression responses that 120 
could be more general and related to overall growth/health performance, whereas intestinal 121 
gene expression would be dominated by specific responses to SBM. 122 
2. Materials and Methods 123 
2.1. Nutritional trial, diets and sampling 124 
The nutritional trial was conducted at the Institute of Marine Research, Matre, Norway using 125 
Atlantic salmon (Salmo salar) of the commercial Aquagen strain (Aquagen Ltd, 126 
Kyrksæterøra, Norway). The fish were normal smolts (1+) produced in 5 m indoor tanks 127 
under natural photoperiod (June 2012). A total of 540 fish were anaesthetized in Finquel, 128 
tagged with PIT tags, and equally distributed into 12 white fiberglass tanks each holding 129 
400 L (95 cm x 95 cm x 60 cm, L x W x H). The tanks were closed with lids, and supplied 130 
with two fluorescent light tubes (18 W each) and an automatic feeder (ARVO-TEC T Drum 131 
2000, Arvotec, Huutokoski, Finland). After two days, the salinity was gradually increased 132 
from freshwater to full salinity (35 ppt) and the temperature adjusted to 12 °C (aerated and 133 
temperature-controlled seawater). Water flow was fixed at 20 L min
-1
. Fish were acclimatized 134 
for 4-weeks during which time they were all fed the same feed (S0, Table 1). Two days prior 135 
to the start of the trial, the individual fish were weighed (group mean 175 g) and returned to 136 
the tanks. Four dietary treatments were investigated with progressively increasing inclusions 137 
of solvent-extracted soybean meal (SBM; 0 g kg
-1
, 100 g kg
-1
, 200 g kg
-1





substituting other protein sources (FM, corn gluten, sunflower cake and horsebeans) referred 139 
to as diets S0, S10, S20 and S30, respectively (Table 1). Each experimental feed was fed to 140 
triplicate tanks. All feeds were formulated to meet the nutritional requirement of salmon 141 
(National Research Council, NRC, 2011). The feeding trial lasted for 87 days and at the end 142 
of this period individual weights and lengths of all fish were measured and specific growth 143 
rate (SGR) calculated using the following equation [SGR = lnWTfin - lnWTin / days]. In 144 
addition, the same tip of the liver and a portion of the distal (posterior) intestine were 145 
dissected from six individuals per dietary treatment (two per tank replicate). Tissue samples 146 
were immediately placed in RNALater (Life Technologies, Paisley, UK) and processed as per 147 
manufacturer’s instructions before being stored at -20 °C prior to molecular analyses.  148 
2.2. Transcriptomic analysis 149 
Transcriptomic analysis was conducted using an Atlantic salmon custom-designed 4 x 44K 150 
oligo microarray (Agilent Technologies, Wokingham, UK; ArrayExpress accession no. A-151 
MEXP-2065) as described in detail previously (Tacchi et al., 2011). The salmon custom array 152 
and laboratory procedures utilized have been widely used and extensively validated in 153 
previous studies (e.g. Bicskei et al., 2014, Martinez-Rubio et al., 2012, Morais et al., 2012a, 154 
Morais et al., 2012b, Tacchi et al., 2011, Tacchi et al., 2012). Briefly, total RNA was 155 
extracted from individual samples using TRI Reagent according to the manufacturer’s 156 
instructions (Sigma-Aldrich, Dorset, UK), including a high salt precipitation as recommended 157 
for polysaccharide-rich tissues such as liver (Chomczynski and Mackey, 1995). RNA 158 
quantity, integrity and purity were assessed by agarose gel electrophoresis and 159 
spectrophotometry (NanoDrop ND-1000, Thermo Scientific, Wilmington, USA). Equal 160 
amounts of RNA from six individual fish liver and intestine tissues were analyzed. The 161 
resulting RNA samples were amplified using a TargetAmp™ 1-Round Aminoallyl-aRNA 162 
Amplification Kit, (Epicentre Technologies Corporation, Madison, Wisconsin, USA) 163 
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following recommended procedures and purified through a RNeasy Mini spin column 164 
(Qiagen, Manchester, UK). Aminoallyl-amplified RNA (aRNA) samples were individually 165 
labelled with Cy3 dye (GE HealthCare Life Sciences, Buckinghamshire, UK), while a pool of 166 
all aRNA samples was labelled with Cy5 dye (GE HealthCare Life Sciences) and used as a 167 
common reference. Unincorporated dye was removed by purifying the aRNA samples with an 168 
Illustra AutoSeq G-50 dye terminator column (GE HealthCare Life Sciences). Successful dye 169 
incorporation and sample integrity was assessed for 0.4 µL aliquots of labelled samples by 170 
agarose gel electrophoresis followed by fluorescent detection of aRNA products (Typhoon 171 
scanner, GE Healthcare Life Sciences). Cy dye concentration and aRNA quantification were 172 
measured by Nanodrop mediated spectrophotometry (Thermo Scientific, Wilmington, USA).  173 
Labelled aRNA samples were hybridized to the custom-made array. A dual-label common 174 
reference design was adopted, where equal amounts of each individual aRNA sample and the 175 
common reference pool were competitively hybridized on an array. The common reference 176 
design allowed standardization of inter- and intra-array variability. A total of 24 samples (two 177 
tissues x two treatments x six replicates) were processed with the Gene Expression 178 
Hybridization Kit (Agilent Technologies), applied to the arrays and immediately incubated 179 
using SureHyb hybridization chambers in a DNA Microarray Hybridization Oven (Agilent 180 
Technologies) at 65 °C for 17 h. Throughout the experiment samples were randomized, 181 
preventing samples from the same treatment being overrepresented in a particular batch in 182 
order to avoid unintentional biases. Scanning was performed using a GenePix 4200 AL 183 
Scanner (Molecular Devices (UK) Ltd., Wokingham, UK) and the resulting images analyzed 184 
with Agilent Feature Extraction Software v.9.5 (Agilent Technologies) to extract the intensity 185 
values and identify the features. The foreground intensity was computed as the mean value of 186 
pixels, considered a better estimator as being less susceptible to distortion from outlier values 187 
(Russell et al., 2009), while background intensities were computed as the median value of 188 
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pixels. Details of the microarray experiment have been submitted to ArrayExpress and 189 
assigned the accession number E-MTAB-3291.   190 
  191 
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2.3. Data pre-processing and differential expression analysis 192 
Transcriptomic data analysis was performed using R v.3.0.1 and Bioconductor v.2.13 193 
(Gentleman et al., 2004, R Core Team, 2013). Quality control, data pre-processing and 194 
identification of differentially expressed features/genes were conducted using the software 195 
package limma (Smyth, 2004). Array quality was assessed by visualizing and comparing 196 
boxplots of red (R) and green (G) background and foreground intensities, MA plots [M = 197 
log2(G/R); A = 1/2log2(R*G)] and spatial heterogeneity to reveal the presence of any 198 
technical bias. Following this quality assessment, all arrays were retained for further analyses.  199 
Features considered outliers in two or more replicates within at least one treatment were 200 
excluded from further analyses. Foreground intensities were background-corrected using the 201 
normexp approach (maximum likelihood variant “mle”, offset = 50) as previously reported as 202 
the most reliable method for two-color microarrays where background estimates are available 203 
(Ritchie et al., 2007, Silver et al., 2009). Data were log-transformed and normalized using the 204 
function normalizeWithinArrays (method = “loess”) and normalizeBetweenArrays (method = 205 
“RQuantile”) (Smyth and Speed, 2003). Controls and features expressed just above 206 
background (A values < 6) were also removed.  207 
Features of the array were annotated using BLAST 2.2.29+ (blastx) against the entire non-208 
redundant protein database as well as using the KEGG Automatic Annotation Server to obtain 209 
functional annotations (Altschul et al., 1990, Moriya et al., 2007). A total of 89.6 % of all 210 
probes were returned with a BLAST annotation (annotation date May 2014) with e-value 211 
<  0.001, while 59 % of probes were returned with a functional annotation (KEGG identifier) 212 
using the KAAS server. Differentially expressed features between treatments were estimated 213 
by least squares fitting of linear models on a probe-by-probe basis using the entire pre-214 
processed dataset. The function lmFit was used to compute differential expression and 215 
statistics were extracted using ebayes (trend = TRUE), both limma functions (Smyth, 2004). 216 
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Features representing the same target gene as implied from KEGG annotation were merged 217 
into a unique value obtained by selecting the feature with the highest F-value. A new dataset 218 
was therefore generated for further analyses where each gene was only represented by one 219 
feature. Merging resulted in a dataset of 6729 annotated features targeting unique genes. 220 
2.4 Data Mining 221 
Hierarchical Clustering. Hierarchical cluster analysis was performed on gene expression 222 
normalized values to evaluate overall similarity between samples and analyzed using the R 223 
package pvclust (Suzuki and Shimodaira, 2011). “Correlation” was used as the distance 224 
measure using 1000 bootstrap replication.    225 
Overview of differential expression. Differentially expressed genes were plotted using the R 226 
package ggplot2 (Wickham, 2009). For figures involving functional information, the KEGG 227 
database was used as the chosen classification system. Venn diagrams were generated using 228 
the function VennDiagram from the limma software package and modified using ggplot2.  229 
Gene-Set Enrichment Analysis (GSEA). Unique annotated sequences were analyzed using the 230 
R function gage of the software package GAGE (Generally Applicable Gene-set Enrichment, 231 
Luo et al., 2009) to identify mechanistic changes as suggested by coordinated expression 232 
changes in gene-sets. For completeness, two types of test were performed: 1 direction (1d), 233 
testing all genes in a gene-set moving towards the same direction; and 2 directions (2d), 234 
testing genes in a gene-set that move towards both directions. Gene-sets with a q-value < 0.1 235 
were considered significant, where the q-value represented the p-value adjusted for false 236 
discovery rate. KEGG classification was used for these analyses and all figures were 237 
produced using the software package ggplot2.   238 
  239 
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3. Results 240 
3.1 Growth performance 241 
There were no significant differences in recorded mortality between treatments. Dietary SBM 242 
inclusion of 300 g kg
-1
 (i.e. feed S30) induced statistically significant growth retardation in 243 
salmon in terms of both final weight and specific growth rate (SGR) compared to fish fed all 244 
other treatments (Table 2). The SGR of salmon fed SBM at an inclusion level of 200 g kg
-1 
245 
was significantly lower than fish fed S0 or S10, but significantly higher than fish fed S30, 246 
although final weights were not different to fish fed the diets with lower inclusion of SBM. 247 
Based on these data, transcriptome analyses were performed on tissue samples from fish fed 248 
diets S0 and S30 to guarantee the largest difference between samples and increase the 249 
possibility to detect differential expression. 250 
3.2 Transcriptome analysis: Overview 251 
Hierarchical clustering performed on the normalized gene expression data indicated the 252 
existence of a clear structure in the dataset with four main clusters (Fig. 1). A clear separation 253 
was evident between the liver and the intestine forming two independent clusters fully 254 
supported by bootstrap values (100). Within each tissue cluster, the dietary treatments S0 and 255 
S30 also induced clearly identifiable differential gene expression responses. The liver 256 
demonstrated a weaker, but significant, bootstrap support (63-80), compared with the 257 
response of the intestine that was fully supported by statistical bootstraps (100), indicating a 258 
less defined response in the liver compared with that of the intestine.   259 
The analysis of differential expression computed by limma reflected the structure observed by 260 
hierarchical clustering, indicating a less pronounced, but still evident response in liver, where 261 
133 genes were differentially expressed (p < 0.01, absolute FC > 1.3), compared to a marked 262 
response in the intestine where a total of 1918 transcripts were differentially expressed 263 
(p < 0.01, absolute FC > 1.3). The difference between the two tissues was again apparent in 264 
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that the differentially expressed transcripts of the liver showed a generally decreased (fold 265 
change) and less significant (p value) response compared with that of the intestine (Fig. 2a, b). 266 
Due to the minor transcriptional effect observed in the liver associated with primary 267 
metabolic role, the use of multiple testing corrections (Benjamini-Hochberg) on this tissue 268 
returned only 11 genes below the adjusted cutoff p value of 0.05 and proved to be over-269 
conservative. Applying multiple testing correction (adj. p < 0.05) in the intestine resulted in 270 
2664 differentially expressed genes. For consistency between the tissues we therefore elected 271 
to consider all genes with a p < 0.01 and absolute FC > 1.3 to be truly differentially 272 
expressed.    273 
A total of 44 genes were significantly affected in both tissues, while the remaining 88 and 274 
1873 genes were represented exclusively as tissue-specific responses in the liver and intestine 275 
respectively. Of the 44 genes affected in both liver and intestine, 31 were regulated in the 276 
same direction (i.e. either up- or down-regulated in both tissues) possibly indicating a 277 
systemic response, while 13 were regulated in opposite directions (Table 3). Expression was 278 
always calculated relative to the S0 treatment. Amongst the genes whose transcript abundance 279 
increased in both liver and intestine, there was an over-representation of ribosomal subunits 280 
(L5, L21, L11, L7, S3A); enzymes involved in ribosome biogenesis such as ribonucleases 281 
P/MRP protein subunit RPP25 and casein kinase II subunit alpha; proteins participating in 282 
RNA processing such as translation initiation factor 5, cleavage and polyadenylation 283 
specificity factor subunit 5 and the spliceosome component U5 snRNP protein and factors 284 
engaged in protein processing such as ER degradation enhancer, mannosidase alpha 3 (Table 285 
3). In addition, other important genes that concurrently increased in both tissues included bile-286 
salt stimulated lipase, complement component C7, sulfinoalanine decarboxylase and an 287 
enzyme involved in fatty acid β-oxidation, carnitine O-palmitoyltransferase 1. In contrast, 288 
down-regulated genes coded for proteins involved in metabolic processes such as lipid 289 
metabolism (glycerol kinase, elongation of very long chain fatty acids protein 5, very long 290 
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chain-3 hydroxyacyl-dehydratase), sugar metabolism (GDP-L-fucose synthase) and glycan 291 
metabolism (alpha-1,6-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase).  292 
The following sections (sections 3.3 and 3.4) report on the tissue-specific responses. Gene-set 293 
enrichment analysis was utilized as a tool to identify mechanistic changes of groups of genes. 294 
However, while the limited number of differentially expressed genes identified in the liver 295 
also allowed a more in-depth analysis on individual genes, this approach was not possible 296 
with the distal intestine without introducing bias in selecting the gene list. Thus, in the distal 297 
intestine only gene-set enrichment analysis was applied representing a more robust approach 298 
compared to individual gene analysis. The liver was found to be only marginally affected, 299 
whereas a large number of gene-sets were significantly affected (q < 0.1) in the intestine, 300 
clearly reflecting the trend identified above targeting differentially expressed genes.  301 
3.3 Liver 302 
Compared with the distal intestine, the liver was partially affected by diet S30 (Fig. 2) with 303 
only 88 genes uniquely differentially expressed compared to fish fed diet S0, although a set of 304 
key pathways were significantly affected (Fig. 3). The 2d test was able to capture the most 305 
significantly perturbed pathways possessing genes both up and down-regulated. The most 306 
affected pathway in this category was the complement and coagulation cascades. A closer 307 
view on the complement cascade is shown in Fig. 4. Other affected processes identified by the 308 
2d test included lipid metabolism; in particular lipid digestion and absorption, regulation of 309 
steroid biosynthesis and the PPAR signalling pathway, amino acid metabolism; principally 310 
glycine/serine/threonine and alanine/aspartate/glutamate metabolism and metabolism of 311 
vitamins (retinol) including vitamin digestion and absorption. In contrast, the 1d GAGE test 312 
was able to address expression changes in genes moving in the same direction, either up or 313 
down-regulated, and was particularly helpful in identifying the overall trend of expression 314 
within a specific pathway. This analysis indicated an up-regulation of the PI3K-Akt signalling 315 
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pathway and a down regulation of oxidative phosphorylation, proteasome apparatus, protein 316 
export and terpenoid backbone biosynthesis.  317 
In Table 4, a selection of the genes differentially expressed only in the liver is listed. To 318 
minimize bias, we included most of the genes involved in the function of interest (the full list 319 
included 40 of the 88 affected genes). These included the up-regulation of several genes 320 
coding for pancreatic enzymes such as trypsin, carboxypeptidase B, etc. and bile salt-321 
stimulated lipase, and key genes participating in energy metabolism for instance, 2-322 
oxoglutarate dehydrogenase and succinate dehydrogenase (citric acid cycle). Generally, 323 
down-regulated genes were shown to relate to amino acid, lipid and sterol metabolism (Table 324 
4). Interestingly, ribosomal genes that were affected only in the liver were all down-regulated, 325 
in contrast with those affected in both tissues that were up-regulated. Finally, genes 326 
contributing to the innate immune response were also significantly altered in liver, where the 327 
complement cascade pathway possessed the highest significance score. Genes of this pathway 328 
that were significantly up-regulated included complement components 3 (C3), that was only 329 
affected in the liver (p < 0.001, Table 4), and C7 that was up-regulated in both tissues in 330 
tandem (Table 3). In addition, other genes of the complement cascade such as C5, C6, 331 
complement component receptor type 2, the mannan-binding lectin serine protease 1 332 
(MASP1) and the CD59 antigen were also perturbed to a lesser extent (p < 0.05) and are 333 
shown in Fig. 4. 334 
3.4 Distal Intestine 335 
The distal intestine showed a pronounced global response, involving gene-sets regulating a 336 
number of processes (Fig. 4). This response at a gene-set level is summarized by the major 337 
biological processes affected in the intestine identified in both GAGE 1d and 2d analyses and 338 
included primarily metabolic (e.g. lipid, amino acid and energy metabolism), organismal 339 
 16 
 
systems (e.g. digestion and absorption, immune and endocrine system) and other cellular 340 
processes including pathways involved in the protein synthesis.  341 
For clarity of presentation and due to the number of pathways identified in the intestine, 342 
pathways were separated into “highly significantly different” (q < 0.0001) and “significantly 343 
different” (0.1 < q < 0.0001), however this should not minimize the importance of pathways 344 
with lower q values. Among the highly significantly regulated gene-sets identified through the 345 
2d test (q < 0.0001) were pathways associated with phagocytosis (cellular organelles 346 
lysosome and phagosome), lipid and vitamin digestion and absorption pathways, PPAR 347 
signalling pathway of the endocrine system, antigen processing and presentation (immune 348 
system) and key metabolic pathways including glycan degradation, amino sugar and 349 
nucleotide sugar degradation, retinol metabolism, arginine/proline metabolism, 350 
alanine/aspartate/glutamate metabolism and glutathione metabolism (Fig. 5a). Only one 351 
immune pathway, antigen processing and presentation, was identified by the 2d test with a 352 
highly significant q value. A further 22 pathways, mainly metabolic (n= 15), were 353 
differentially expressed below the q = 0.0001 cut-off (Fig. 5a).  354 
Interestingly, only two pathways classified as “genetic information processing” were 355 
identified by the 2d test and included the proteasome complex and aminoacyl-tRNA 356 
biosynthesis. Notably, the 1d test revealed that this category of pathways was significantly 357 
up-regulated, with most pathways exhibiting a highly significant q value (< 0.0001) (e.g. 358 
ribosome, proteasome, spliceosome, RNA transport, etc., Fig. 5b). Furthermore, other gene-359 
sets with increased expression in fish fed the S30 treatment comprised those regulating 360 
functions such as cell growth and death, cell cycle, apoptosis and MAPK signalling (Fig. 5b). 361 
An overall increased expression was also observed in a number of immune pathways. The 362 
immune response involved up-regulation of the TNF signalling pathway (p < 0.0001), NOD-363 
like receptor interaction, NF-kB signalling pathway, cytosolic DNA sensing pathway, Jak-364 
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STAT signalling pathway, cytokine-cytokine receptor interaction and T-cell receptor 365 
signalling pathway (Fig. 5b).  366 
. 367 
A number of gene-sets that tested significant in the 2d test were also significant with the 1d 368 
test, particularly amongst the down-regulated pathways (Fig. 5b). These included gene-sets 369 
centred on metabolic pathways and processes such as digestion and absorption of proteins, 370 
lipids, vitamins and minerals, indicating the genes underlying these processes were primarily 371 
decreased in response to diet S30. Finally, the 1d test revealed that proteins associated with 372 
the lysosome and peroxisome organelles were also reduced (Fig. 5b).  373 
4. Discussion 374 
The present study reports a molecular snapshot reflecting the hepatic and intestinal (distal) 375 
physiology of Atlantic salmon exposed to a plant-based nutritional stress. The results herein 376 
were produced utilizing an unbiased global analysis approach to identify mechanistic changes 377 
of gene expression with the precise aim of avoiding the bias and restrictions often associated 378 
with the selection of limited gene lists. The study aimed to provide a platform to screen the 379 
most perturbed processes and identify molecular markers useful for phenotyping and 380 
discriminating influential processes affected in response to diets formulated with high levels 381 
of plant-based ingredients. The complete lists of differentially expressed genes identified are 382 
publicly available and can be consulted for further information on Array Express (accession 383 
number E-MTAB-3291).  384 
The nutritional trial revealed that dietary SBM reduced growth performance in salmon when 385 
included at levels over 200 g kg
-1
. It was not within the scope of the study to determine in 386 
detail the performance of salmon in response to dietary SBM inclusion, since this had already 387 
been investigated previously and the effects on growth were in agreement with those observed 388 
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in the present trial (growth data reviewed in Collins et al., 2013, health effects reviewed in 389 
Krogdahl et al., 2010). The aim of this nutritional trial was solely to reproduce the expected 390 
effects and provide an experimental model of nutritional stress that would satisfy the 391 
objectives of the present gene expression study. The experimental model included two lower 392 
inclusion levels (100 g kg
-1
 and 200 g kg
-1
) that did not show consistent and/or significant 393 
growth retardation compared with the control diet (S0). However, the results could provide 394 
experimental material to test the potential molecular biomarkers and hypothesis developed in 395 
the current study in dietary treatments that have only “subclinical” effects on performance.  396 
The detected differential transcriptomic response observed in salmon fed 300 g kg
-1
 SBM 397 
compared to FM control was greater in the distal intestine compared to the liver. These results 398 
were expected due to the inflammation of the distal intestine and consequent immune 399 
response that is generally observed after feeding similar levels of dietary SBM (Baeverfjord 400 
and Krogdahl, 1996, Bakke-McKellep et al., 2007, Urán et al., 2008, Urán et al., 2009). Since 401 
not directly affected by the contact with the feed itself and hence the ANFs, the liver response 402 
was different and possibly accessory to that of the intestine. While in the former we observed 403 
processes related to the immune response, cell growth and regeneration and evidence of 404 
impairment of metabolic functions, the liver showed activation of mainly metabolic pathways 405 
and an immune response that reflected the inflammation observed locally in the distal 406 
intestine.  407 
The role played by the liver in the physiological response to plant-based nutritional stress is 408 
not fully understood. Kortner and colleagues (2013) reported an increase of hepatic 409 
cholesterol metabolism suggesting it was a compensatory response to reduced dietary uptake 410 
through endogenous cholesterol biosynthesis. However, this was in contrast to results from 411 
the present study where all genes of lipid and sterol metabolism were down regulated in liver 412 
with the exception of cholest-5-ene-3beta,7alpha-diol 3beta-dehydrogenase (up-regulated), 413 
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which is involved in the initial stages of bile acid synthesis from cholesterol (Schwarz et al., 414 
2000). The discrepancy observed might indicate that a different response is to be expected 415 
depending upon SBM dietary inclusion level and, most importantly, the severity of the 416 
immune response. Whichever the case, it is evident that the cholesterol pathway and its 417 
underlying genes might represent a reliable marker describing the nutritional status of fish and 418 
should be further investigated.    419 
A well-known characteristic and important limitation of plant ingredients is the presence of 420 
protease inhibitors, proteins involved in the plant’s defence mechanisms against herbivores 421 
(Hartl et al., 2011). Protease inhibitors are tightly linked to proteins and might consequently 422 
be co-extracted with the protein fraction during the production of concentrates. In the gut 423 
lumen, protease inhibitors impact on feed digestibility supposedly by interfering with 424 
endogenous proteases such as trypsins, chymotrypsins, etc., which in turn can result in over-425 
secretion of these enzymes from pancreatic tissue and consequent loss of endogenous 426 
resources (e.g. sulphur-rich amino acids methionine and cysteine), eventually leading to 427 
decreased growth (Chikwati et al., 2012, Sarwar-Gilani et al., 2012). In salmon liver, we 428 
detected a significantly increased expression of genes coding for pancreatic enzymes such as 429 
proteases (trypsin, chymotrypsin, etc.) and lipases. This was not surprising considering that 430 
fish liver contains several cell types including pancreatic-like cells (Rust, 2002). These results 431 
may resemble the “hyperactive pancreas” syndrome observed in mammals (Sarwar-Gilani et 432 
al., 2012) and encourage further investigation of these genes as biomarkers for protein 433 
digestibility.  434 
At a metabolic level, a number of key hepatic genes involved in amino acid metabolism were 435 
down-regulated including those coding for enzymes catalysing the degradation of essential 436 
amino acids such as threonine (glycine C-acetyltransferase), tryptophan (indoleamine 2,3-437 
dioxygenase) and methionine (S-adenosylmethionine synthetase) which suggested a 438 
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compensatory response to preserve these important nutrients. There was also up-regulation in 439 
liver of two genes fundamental to the citric acid cycle (2-oxoglutarate dehydrogenase and 440 
succinate dehydrogenase), which suggested an activation of energy metabolism. Interestingly, 441 
the up-regulation of the carnitine O-palmitoyltransferase gene, involved in the β-oxidation of 442 
fatty acids via the synthesis of acyl-CoA, possibly reflected the undernourished condition of 443 
fish fed 300 g kg
-1
 SBM, with the liver approaching a ketotic state. This is consistent with a 444 
previous study demonstrating a number of similarities in the hepatic response of Atlantic 445 
salmon to restricted feeding and feed containing extracted SBM (Skugor et al., 2011). 446 
Expression data from the liver suggested that this organ also participated in the innate 447 
immune response at a systemic level. This was evident from the up-regulation of several 448 
genes of the complement cascade, which plays a crucial role in mediating non-specific 449 
defence against pathogens in the blood, and the liver is the major site of production of 450 
complement proteins (Jain et al., 2014). The up-regulation of the MASP1 genes suggested 451 
that activation of the cascade possibly occurred through the lectin pathway, which is 452 
stimulated through recognition of carbohydrates or glycoproteins present on invading 453 
pathogens or at the lesion. Notably, CD59 antigen abundance decreased, suggesting a 454 
stimulation of the formation of the membrane attack complex that is formed as an end result 455 
of the complement cascade. Activation of proteins of the complement cascade in the liver was 456 
not reported previously in Atlantic salmon fed a lower level (200 g kg
-1
) of SBM (Skuggor et 457 
al., 2011). Since the microarray utilized in the earlier study (NCBI GEO Omnibus GPL6154) 458 
contained probes targeting several complement component proteins, it can be hypothesized 459 
that the activation of this pathway may occur at SBM inclusions above 200 g kg
-1
 and that 460 
below this level the process remains more localized to the intestine. 461 
The gene expression response detected in the distal intestine was consistent with the results of 462 
recent studies investigating SBM-induced enteritis (Sahlmann et al., 2013) and that caused by 463 
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pea protein concentrate supplemented with soyasaponin (Kortner et al., 2012), and 464 
significantly overlapped with the immune response developed during human inflammatory 465 
bowel disease (Maloy and Powrie, 2011). The present results confirmed, at an individual gene 466 
level (dataset available as supplementary material in Array Express), the majority of the 467 
immune-related responses of chronically inflamed distal intestine in salmon reported 468 
previously (Kortner et al., 2012, Skugor et al., 2011). These included a) the activation of T-469 
cell mediated processes via the up-regulation of the CD86 antigen, CTLA4 IL-18 and IL-22 470 
and increased expression of T-cell receptors, which was also confirmed by the up-regulation 471 
of the T-cell receptor signalling pathway identified by gene-set analysis; b) activation of 472 
TNF- and NF-kB-mediated response and up-regulation of components of the respiratory burst 473 
complex through the up-regulation of the TNF signalling pathway, a critical trigger for the 474 
release of pro-inflammatory cytokines and also the activation of a number of intracellular 475 
pathways eventually leading to apoptosis and cell survival (Chu, 2013); and finally  c) up-476 
regulation of anti-inflammatory proteins, notably annexin A1, that was found to increase by 477 
approximately 10-fold in agreement with previous studies (Kortner et al., 2012). All these 478 
genes represent an informative pool of potential molecular markers of the immune response in 479 
the salmon intestine. More focused immunological analyses of intestinal transcriptome 480 
profiling during the development of enteritis have been reported previously (Kortner et al., 481 
2012, Sahlmann et al., 2013). In addition to these results, we reported a notable intestinal up-482 
regulation of a set of pathways involved in protein synthesis (ribosome, proteasome, tRNA 483 
biosynthesis, RNA transport, etc.) and cell proliferation (cell cycle, apoptosis, etc.) that 484 
implied active regeneration of the damaged intestinal tissue. 485 
Metabolic pathways and other cellular and physiological processes such as digestion and 486 
absorption of nutrients (proteins, lipid, vitamins and minerals) were also significantly affected 487 
in the distal intestine. A down-regulation of virtually all metabolic pathways following the 488 
SBM-induced nutritional stress was observed, consistent with studies indicating that distal 489 
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intestine undergoing severe inflammation was characterized by “tissue malfunction” (Kortner 490 
et al., 2012, Sahlmann et al., 2013). Studies from other fish species revealed that impaired 491 
metabolism could also develop independently from the immune response (Murray et al., 492 
2010), which suggested that some of the effects on metabolism might be possibly associated 493 
with the nutritional properties of SBM or plant products in general rather than tissue 494 
malfunction per se. To better identify and characterise these processes it will be necessary to 495 
analyse dietary treatments inducing a lower (subclinical) level of stress that does not directly 496 
affect the functionality of the intestine (e.g. 100 g kg
-1
). Marked down-regulation of genes 497 
involved in cellular processes associated with lysosomes, peroxisomes and, to a lesser extent, 498 
phagosomes, whose primary role is the degradation of various cellular metabolites, as well as 499 
the digestion of invading pathogens, was possibly also linked to the tissue impairment.  500 
Amongst the processes affected, lipid and in particular sterol metabolism in the distal intestine 501 
appeared to be altered by the use of plant proteins. We observed a down-regulation of the 502 
genes involved in several pathways of lipid metabolism, digestion and absorption, primary 503 
bile acid biosynthesis and secretion. This was in agreement with previous observations in 504 
salmon fed 200 g kg
-1
 SBM where processes of lipid and bile uptake were impaired (Kortner 505 
et al., 2013). It is unclear whether impaired lipid metabolism in the distal intestine was a 506 
consequence of the tissue damage or if it was affected by the presence of certain ANFs such 507 
as, for example, soyasaponins, that interfere with the normal absorption of these nutrients and 508 
are known to cause hypocholesterolemia (Francis et al., 2001, Francis et al., 2002, Gu et al., 509 
2014, Kortner et al., 2013).  510 
In conclusion, the present study contributes towards the development of a nutrigenomic 511 
model describing molecular signatures observed following nutritional stress induced by 512 
dietary plant proteins. Our results build on recent nutrigenomic findings in Atlantic salmon 513 
fed pea protein concentrate and on those of salmon undergoing restricted/SBM feeding 514 
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towards the identification of diagnostic markers in the intestine. More importantly, the 515 
analyses of the liver transcriptome provided a platform for selection of responses that could 516 
be more general and related to the overall performance, and hence have the potential as 517 
predictive markers for monitoring health, welfare and performance traits. This study is a 518 
comprehensive report on transcriptome profiles of distal intestine and liver, highlighting the 519 
role of the latter tissue in fish undergoing SBM-induced nutritional stress.  520 
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Figure Legends 688 
Figure 1. Hierarchical clustering of gene expression profiles in liver and intestine. Two types 689 
of p-values are provided: AU (Approximately Unbiased) is computed by multiscale bootstrap 690 
resampling (1000 rep) and reported in red and BP (Bootstrap Probability) is computed by 691 
normal bootstrap resampling and reported in green.  692 
Figure 2. Histograms plotting the results of differential expression analysis in liver and 693 
intestine of salmon fed diet S30 compared to fish fed diet S0. Figure 2a plots the number of 694 
differentially expressed genes based on p value and indicates that a larger number of genes 695 
with a p < 0.01 (the dashed line depict the p value = 0.01) were present in the intestine 696 
compared to the liver. Figure 2b only plots genes with p < 0.01. FC is fold change. 697 
Figure 3. Bubble graph plotting GAGE results from the 2d test (a) and 1d test (b) in the liver. 698 
The x-axis plots the fold change (mean statistic) while the y-axis plots the Log10 transformed 699 
q-value. The size of the bubbles is proportional to the number of genes used by the algorithm 700 
to test the gene-set. Colours of bubbles refer to the biological process (KEGG classification). 701 
Figures are not on the same scale. 702 
Figure 4 Complement cascade generated with the R package pathview of affected genes in 703 
the liver (Luo and Brouwer, 2013). Red arrows indicate activation, blue arrow inhibition and 704 
dotted arrows indirect effect. Highlighted in blue are the names of the differentially expressed 705 
genes and the corresponding KEGG identifier.   706 
Figure 5. Bubble graph plotting GAGE results from the 2d test (a) and 1d test (b) in the 707 
intestine. The x-axis plots the fold change (mean statistic) while the y-axis plots the Log10 708 
transformed q-value. The size of the bubbles is proportional to the number of genes applied 709 
by the algorithm to test the gene-set. Colours of bubbles refer to the biological process type 710 
(KEGG classification). The dashed line denotes the cut-off of “highly significant gene-sets” 711 
(q < 0.0001). Figures are not on the same scale.  712 
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Table 1. Formulation (g / Kg) and analyzed proximate compositions 713 
of the experimental diets 714 
  S0 S10 S20 S30 
Fishmeal
1 
 420.10 368.00 344.00 291.00 
Hi-Pro Soymeal
2
 0.00 100.00 200.00 299.50 
Corn gluten 60 77.00 77.00 33.00 23.00 
Sunflower cake 125.00 104.70 95.80 70.60 
Horsebeans 160.00 135.60 105.30 85.30 
Fish oil std 18 154.00 158.00 164.00 170.00 
Rapeseed oil 40.00 40.00 40.00 40.00 
Amino acids 5.70 6.40 7.30 12.10 
Vitamins and Minerals 31.90 31.90 31.90 31.90 
 
Proximate composition 
    Protein - crude (%) 44.06 44.18 43.83 43.59 
Fat - crude (%) 25.97 25.96 25.96 26.02 
Ash (%) 7.28 7.47 7.75 7.42 





Soya cake 48 Hi-Pro (solvent extracted soybean meal cake)  716 
All values are represented as g kg
-1
 unless otherwise stated. 717 
 718 
  719 
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Number of fish in each triplicate tank was 45. Weights are in g. Calculations of SGR (specific 722 
growth rate) were based on growth of individual fish. Values within a column not sharing 723 
superscript letters are significantly different (p < 0.05). Growth data was compared using a 724 
one-way ANOVA for statistical significance.  725 
  726 
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Table 3. Forty-four genes differentially expressed (p < 0.01) in both liver and intestine of fish 
fed S30 compared with S0. LogFC is the log2 transformed fold change. 
    LIVER INTESTINE 
KOID Description LogFC P.Value LogFC P.Value 
K02377 GDP-L-fucose synthase  -1.01 0.0028 -4.15 < 0.0001 
K15985 cAMP-dependent protein kinase inhibitor alpha -0.68 0.0013 -1.22 < 0.0001 
K00736 alpha-1,6-mannosyl-glycoprotein beta-1,2-N-
acetylglucosaminyltransferase  
-0.54 0.0035 -1.17 < 0.0001 
K00864 glycerol kinase  -0.53 0.0050 -1.10 < 0.0001 
K03940 NADH dehydrogenase (ubiquinone) Fe-S protein 7  -0.53 0.0076 -0.75 0.0004 
K11251 histone H2A -0.53 0.0066 -0.79 0.0002 
K10244 elongation of very long chain fatty acids protein 5  -0.52 0.0039 -1.12 < 0.0001 
K10703 very-long-chain (3R)-3-hydroxyacyl-dehydratase  -0.50 0.0013 -1.22 < 0.0001 
K00522 ferritin heavy chain  -0.40 0.0063 -0.85 < 0.0001 
K04644 clathrin light chain A -0.37 0.0031 -0.51 0.0001 
K11428 histone-lysine N-methyltransferase SETD8  -0.30 0.0034 -0.28 0.0057 
K06109 Ras-related protein Rab-13 -0.29 0.0074 -0.46 < 0.0001 
K02977 small subunit ribosomal protein S27Ae -0.23 0.0099 -0.24 0.0064 
K09850 Ras association domain-containing protein 1 0.26 0.0084 0.27 0.0063 
K14525 ribonucleases P/MRP protein subunit RPP25  0.33 0.0023 0.55 < 0.0001 
K12859 U5 snRNP protein, DIM1 family 0.34 0.0090 0.40 0.0024 
K02932 large subunit ribosomal protein L5e 0.35 0.0091 0.59 < 0.0001 
K02889 large subunit ribosomal protein L21e 0.35 0.0049 0.57 < 0.0001 
K03262 translation initiation factor 5 0.36 0.0019 0.35 0.0027 
K02868 large subunit ribosomal protein L11e 0.38 0.0016 0.51 < 0.0001 
K02984 small subunit ribosomal protein S3Ae 0.39 0.0051 0.53 0.0003 
K00940 nucleoside-diphosphate kinase  0.40 0.0064 0.60 0.0001 
K12298 bile salt-stimulated lipase  0.41 0.0004 0.30 0.0058 
K03996 complement component 7 0.41 0.0061 0.52 0.0009 
K10086 ER degradation enhancer, mannosidase alpha 3 0.43 0.0076 0.43 0.0072 
K03097 casein kinase II subunit alpha  0.47 0.0007 0.58 < 0.0001 
K02936 large subunit ribosomal protein L7Ae 0.52 0.0003 0.70 < 0.0001 
K08765 carnitine O-palmitoyltransferase 1  0.65 0.0023 0.74 0.0007 
K09414 heat shock transcription factor 1 0.77 < 0.0001 0.45 0.0038 
K14397 cleavage and polyadenylation specificity factor 
subunit 5 
0.90 0.0002 0.96 < 0.0001 
K01594 sulfinoalanine decarboxylase  1.03 0.0060 2.56 < 0.0001 
K11262 acetyl-CoA carboxylase / biotin carboxylase  -0.84 0.0015 0.70 0.0068 
K00222 delta14-sterol reductase  -0.61 0.0028 0.64 0.0017 
K01507 inorganic pyrophosphatase  -0.53 0.0042 1.08 < 0.0001 
K01875 seryl-tRNA synthetase  -0.47 0.0043 0.82 < 0.0001 
K04440 c-Jun N-terminal kinase  -0.25 0.0062 0.30 0.0015 
K10577 ubiquitin-conjugating enzyme E2 I  0.32 0.0057 -0.39 0.0011 
K07292 hepatocyte nuclear factor 4-alpha 0.36 0.0035 -0.51 0.0001 
K10574 ubiquitin-conjugating enzyme E2 B  0.38 0.0059 -0.48 0.0008 
K06624 cyclin-dependent kinase inhibitor 1B 0.55 0.0034 -0.81 < 0.0001 
K08550 estrogen receptor alpha 0.63 0.0082 -0.77 0.0015 
K12408 cholest-5-ene-3beta,7alpha-diol 3beta-dehydrogenase  0.68 0.0055 -1.40 < 0.0001 
K01103 6-phosphofructo-2-kinase / fructose-2,6-
bisphosphatase  
0.75 0.0004 -2.99 < 0.0001 
K04630 guanine nucleotide-binding protein G(i) subunit alpha 1.52 0.0018 -4.41 < 0.0001 
Up-regulated genes are highlighted in red, while down-regulated genes in green. Colour 
intensity is relative to the magnitude of change. All expression values are reported as Log2 
fold change (LogFC) relative to the control treatment S0. KOID = KEGG identifier. 
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Table 4. Selection of genes differentially expressed only in the liver of fish fed S30 
compared with S0. LogFC is the log2 transformed fold change. 
Up-regulated genes are highlighted in red, while down-regulated genes in green. Colour 
intensity is relative to the magnitude of change. All expression values are reported as Log2 
fold change (LogFC) relative to the control treatment S0. KOID = KEGG identifier. 
  
 
KOID Gene LogFC P  Value 
Immune System         
Complement Cascade K03990  complement component 3 1.15 < 0.001 
Metabolism 
    Amino acid K00639 glycine C-acetyltransferase -0.49 < 0.001 
Amino acid K00789  S-adenosylmethionine synthetase -0.85 0.003 
Carbohydrate K12047  maltase-glucoamylase 0.62 0.010 
Energy K00164  2-oxoglutarate dehydrogenase E1 component 0.61 < 0.001 
Energy K00234  succinate dehydrogenase (ubiquinone) flavoprotein subunit 0.41 0.003 
Lipid K01597  diphosphomevalonate decarboxylase -0.63 < 0.001 
Lipid K10205  elongation of very long chain fatty acids protein 2 0.54 < 0.001 
Lipid K01830  prostaglandin-H2 D-isomerase -0.65 0.001 
Lipid K07296  adiponectin -0.89 0.002 
Lipid K01823  isopentenyl-diphosphate delta-isomerase -0.63 0.005 
Lipid K00626  acetyl-CoA C-acetyltransferase -0.49 0.005 
Lipid K00869  mevalonate kinase -0.48 0.005 
Lipid K01852  lanosterol synthase -0.41 0.006 
Nucleotide K03010  DNA-directed RNA polymerase II subunit RPB2 -0.43 0.001 
Nucleotide K01489  cytidine deaminase -0.54 0.004 
Vitamin K01435  biotinidase -0.86 < 0.001 
Vitamin K18271  retinol-binding protein 4 -0.90 0.009 
Cell Proliferation 
    Cell Cycle and Apoptosis K04426 mitogen-activated protein kinase 5 0.44 < 0.001 
Cell Cycle and Apoptosis K10858  DNA mismatch repair protein PMS2 -0.44 < 0.001 
Cell Cycle and Apoptosis K04441  p38 MAP kinase 0.54 0.002 
Cell Cycle and Apoptosis K06245  laminin, beta 4 0.49 0.003 
Cell Cycle and Apoptosis K04436  mitogen-activated protein kinase 8 interacting protein 3 0.48 0.003 
Cell Cycle and Apoptosis K10567  endonuclease VIII-like 1 0.47 0.007 
Genetic Information processing 
Proteasome K05610  ubiquitin carboxyl-terminal hydrolase L5 -1.12 < 0.001 
Protein Processing K13431  signal recognition particle receptor subunit alpha -0.59 < 0.001 
Protein Processing K07342  protein transport protein SEC61 subunit gamma and related proteins -0.49 0.004 
Ribosomal K02891  large subunit ribosomal protein L22e -0.62 < 0.001 
Ribosomal K02911  large subunit ribosomal protein L32 -0.52 < 0.001 
Ribosomal K17418  large subunit ribosomal protein L37, mitochondrial -0.48 < 0.001 
Ribosomal K02950  small subunit ribosomal protein S12 -0.40 < 0.001 
Ribosomal K17433  large subunit ribosomal protein L52, mitochondrial -0.52 0.002 
Ribosomal K17430  large subunit ribosomal protein L49, mitochondrial -0.53 0.003 
Ribosomal K17428  large subunit ribosomal protein L47, mitochondrial -0.44 0.003 
Ribosomal K17409  small subunit ribosomal protein S30, mitochondrial -0.45 0.005 
Digestive system 
    Pancreatic K01312 trypsin 1.11 < 0.001 
Pancreatic K01310  chymotrypsin 1.23 < 0.001 
Pancreatic K07886  Ras-related protein Rab-27B 0.58 < 0.001 
Pancreatic K01291  carboxypeptidase B 0.92 < 0.001 
Pancreatic K01346  pancreatic elastase II 0.58 0.001 
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